• FirefoxUpgrade to the new Firefox »
  •  Dow Down 1.45% Nasdaq Down 1.03%

    Ariad Pharmaceuticals Inc. (ARIA)

    -NasdaqGS
    6.45 Up 0.01(0.16%) Jan 30, 4:00PM EST
    |After Hours : 6.50 Up 0.05 (0.78%) Jan 30, 5:59PM EST
    Add to Portfolio
    Prev Close:6.44
    Open:6.39
    Bid:N/A
    Ask:7.90 x 400
    1y Target Est:7.96
    Beta:0.9
    Next Earnings Date:19-Feb-15ARIA Earnings announcement
    Day's Range:6.30 - 6.56
    52wk Range:4.90 - 9.22
    Volume:3,715,622
    Avg Vol (3m):6,035,520
    Market Cap:1.21B
    P/E (ttm):N/A
    EPS (ttm):-1.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARIA

    Comparison

    Symbol% ChgMkt Cap
    ARIAUp 0.16%1.21B
    NVSDown 1.77%233.63B
    PFEDown 1.82%196.90B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.69
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-1.06
    Quarterly EPS Est (Dec-14) :-0.22
    Mean Recommendation*:2.6
    PEG Ratio (5 yr expected):-0.15

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    ARIAD Pharmaceuticals, Inc., an oncology company, is engaged in the discovery, development, and commercialization of medicines for cancer patients. It offers Iclusig (ponatinib), a tyrosine kinase inhibitor for the treatment of adult patients with... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback